Clearside Biomedical, Inc.
CLSDDelisted Dec 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001539029
Clearside Biomedical, Inc. was delisted on Dec 8, 2025; its insiders filed their last Form 4 on Feb 24, 2025; 26 institutions reported holding it in 13F filings for Q3 2025, worth $2.18M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Clearside Biomedical, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 66 | 1 | 67 | +2 |
| Shares | 20.3M | 60.8K | 21.0M | +815.8K (+4.0%) |
| Value | $121.5M | $365.0K | $57.8M | −$63.4M (−52.3%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Clearside Biomedical, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Walleye Capital LLC | 103,771 | $285.0K | 0.01% |
| Principal Financial Group Inc | 65,344 | $180.0K | 0.00% |
| Wedbush Securities Inc | 36,239 | $100.0K | 0.00% |
| Golden State Equity Partners | 30,527 | $84.0K | 0.04% |
| XTX Topco Ltd | 22,581 | $62.0K | 0.04% |
| Jane Street Group, LLC | 20,792 | $57.0K | 0.00% |
| Ameritas Advisory Services, LLC | 20,810 | $57.0K | 0.00% |
| Balyasny Asset Management LLC | 18,763 | $52.0K | 0.00% |
| Old Mission Capital LLC | 16,362 | $45.0K | 0.00% |
| Virtu Financial LLC | 14,573 | $40.0K | 0.00% |
| Exencial Wealth Advisors, LLC | 14,064 | $39.0K | 0.00% |
| Alpine Global Management, LLC | 13,743 | $38.0K | 0.01% |
| Price T Rowe Associates Inc | 11,900 | $33.0K | 0.00% |
| Walleye Trading LLC | 11,456 | $32.0K | 0.00% |
| PDT Partners, LLC | 10,616 | $29.0K | 0.00% |
| Simplex Trading, LLC | 6,017 | $16.0K | 0.00% |
| Royal Bank of Canada | 1,018 | $3.00K | 0.00% |
| Captrust Financial Advisors | 100 | $0 | 0.00% |
Sold out (16)
Institutions that held Clearside Biomedical, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Acuta Capital Partners, LLC | 1,316,268 | $7.90M |
| AJU IB Investment Co., Ltd. | 293,555 | $1.76M |
| Invesco Ltd. | 277,161 | $1.66M |
| EAM Investors, LLC | 247,561 | $1.49M |
| Marshall Wace, LLP | 53,474 | $321.0K |
| Trexquant Investment LP | 43,768 | $263.0K |
| Dynamic Technology Lab Private Ltd | 39,745 | $238.0K |
| Susquehanna Fundamental Investments, LLC | 29,360 | $176.0K |
| Qube Research & Technologies Ltd | 25,815 | $155.0K |
| Squarepoint Ops LLC | 15,466 | $93.0K |
| Capstone Investment Advisors, LLC | 11,856 | $71.0K |
| Vestor Capital, LLC | 9,000 | $54.0K |
| Dorsey Wright & Associates | 9,034 | $54.0K |
| Core Wealth Advisors, Inc. | 500 | $3.00K |
| Harbour Investments, Inc. | 400 | $2.00K |
| Federated Hermes, Inc. | 66 | $1.00K |
Not filed for Q4 2021 yet (1)
Institutions that held Clearside Biomedical, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Ameritas Investment Company, LLC | 60,810 | $365.0K |